KKR & Co. Inc. announced today that it plans to release its financial results for the fourth quarter 2024 on Thursday, February 6, 2025, before the opening of trading on the New York Stock Exchange. A ...
ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback